VIR - Vir Biotechnology, Inc.

QQQ $ 450.22 $ 4.45 (1 %)

DIA $ 395.16 $ 0.63 (0.16 %)

SPY $ 532.81 $ 4.18 (0.79 %)

TLT $ 96.28 $ 0.96 (1.01 %)

GLD $ 224.54 $ 0.55 (0.25 %)

Previous Close

$ 8.71

Open

$ 8.69

Bid

$ 8.69 x 100

Ask

$ 8.71 x 289

Day's Range

$ 8.53 - $ 8.82

52 Week Range

$ 7.61 - $ 13.85

Volume

717,507

Average Volume

Market Cap

1.17B

Beta (5Y Monthly)

$ -0.83

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-01-2024	06-30-2024	10-Q
2	05-03-2024	03-31-2024	10-Q
3	02-26-2024	12-31-2023	10-K
4	11-03-2023	09-30-2023	10-Q
5	08-04-2023	06-30-2023	10-Q
6	05-08-2023	03-31-2023	10-Q
7	02-28-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-09-2022	06-30-2022	10-Q
10	05-05-2022	03-31-2022	10-Q
11	02-28-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-05-2021	06-30-2021	10-Q
14	05-06-2021	03-31-2021	10-Q
15	02-25-2021	12-31-2020	10-K
16	11-10-2020	09-30-2020	10-Q
17	08-11-2020	06-30-2020	10-Q
18	05-12-2020	03-31-2020	10-Q
19	03-26-2020	12-31-2019	10-K
20	11-19-2019	09-30-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Breaking Down Vir Biotechnology: 6 Analyst...
08/02/2024 15:01:06

Barclays Maintains Overweight on Vir Biote...
08/02/2024 14:11:19

Barclays analyst Gena Wang maintains Vir Biotechnology (NASDAQ:VIR) with a Overweight and raises the price target from $27 t...

Trading Halt: Halt status updated at 4:25:...
08/01/2024 20:25:06

Vir Biotechnology Lowers FY 2024 Operating...
08/01/2024 20:22:56

Vir Biotechnology Q2 2024 Adj EPS $(1.02) ...
08/01/2024 20:21:49

Vir Biotechnology (NASDAQ:VIR) reported quarterly losses of $(1.02) per share which missed the analyst consensus estimate of $(...

Vir Biotechnology Enters Exclusive Worldwi...
08/01/2024 20:07:19

Trading Halt: Halted at 4:00:10 p.m. ET - ...
08/01/2024 20:00:13

Vir Biotechnology's Hepatitis Delta Drug C...
06/26/2024 12:06:40

Vir Biotechnology, Inc. (NASDAQ:VIR) today announced that the U.S. Food and Drug Administration (FDA) has cleared its investiga...

Morgan Stanley Maintains Equal-Weight on V...
06/06/2024 13:12:28

Morgan Stanley analyst Michelle Gilson maintains Vir Biotechnology (NASDAQ:VIR) with a Equal-Weight and raises the price tar...

why-is-infectious-disease-focused-vir-biotechnology-stock-trading-higher-on-wednesday

Why Is Infectious Disease-Focused Vir Biot...
06/05/2024 18:51:30

Vir Biotechnology reports promising Phase 2 SOLSTICE hepatitis delta trial results, showing high virologic response and ALT nor...

why-lands-end-shares-are-trading-lower-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why Lands' End Shares Are Trading Lower? H...
06/05/2024 17:04:26

HC Wainwright & Co. Reiterates Buy on Vir ...
06/05/2024 16:20:42

HC Wainwright & Co. analyst Patrick Trucchio reiterates Vir Biotechnology (NASDAQ:VIR) with a Buy and maintains $110 pri...

Needham Maintains Buy on Vir Biotechnology...
06/05/2024 16:19:01

Needham analyst Joseph Stringer maintains Vir Biotechnology (NASDAQ:VIR) with a Buy and raises the price target from $15 to ...

ollies-bargain-outlet-posts-upbeat-earnings-joins-verint-systems-guidewire-software-and-other-big-stocks-moving-higher-on-wednesday

Ollie's Bargain Outlet Posts Upbeat Earnin...
06/05/2024 14:23:46

Vir Biotechnology Announced New Preliminar...
06/05/2024 09:36:18

Evaluating Vir Biotechnology: Insights Fro...
05/24/2024 17:01:04

HC Wainwright & Co. Reiterates Buy on Vir ...
05/24/2024 16:48:41

HC Wainwright & Co. analyst Patrick Trucchio reiterates Vir Biotechnology (NASDAQ:VIR) with a Buy and maintains $110 pri...

Vir Biotechnology's SOLSTICE Data To Be Fe...
05/21/2024 12:30:20

Vir Biotechnology, Inc. (NASDAQ:VIR) today announced the EASL Congress has changed the Company's Phase 2 SOLSTICE hepatitis...

Deep Dive Into Vir Biotechnology Stock: An...
05/07/2024 13:00:33

HC Wainwright & Co. Reiterates Buy on Vir ...
05/07/2024 11:01:54

HC Wainwright & Co. analyst Patrick Trucchio reiterates Vir Biotechnology (NASDAQ:VIR) with a Buy and maintains $110 pri...